» Articles » PMID: 25735931

Tumor Suppressor Candidate 3 (TUSC3) Prevents the Epithelial-to-mesenchymal Transition and Inhibits Tumor Growth by Modulating the Endoplasmic Reticulum Stress Response in Ovarian Cancer Cells

Overview
Journal Int J Cancer
Specialty Oncology
Date 2015 Mar 5
PMID 25735931
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Ovarian cancer is one of the most common malignancies in women and contributes greatly to cancer-related deaths. Tumor suppressor candidate 3 (TUSC3) is a putative tumor suppressor gene located at chromosomal region 8p22, which is often lost in epithelial cancers. Epigenetic silencing of TUSC3 has been associated with poor prognosis, and hypermethylation of its promoter provides an independent biomarker of overall and disease-free survival in ovarian cancer patients. TUSC3 is localized to the endoplasmic reticulum in an oligosaccharyl tranferase complex responsible for the N-glycosylation of proteins. However, the precise molecular role of TUSC3 in ovarian cancer remains unclear. In this study, we establish TUSC3 as a novel ovarian cancer tumor suppressor using a xenograft mouse model and demonstrate that loss of TUSC3 alters the molecular response to endoplasmic reticulum stress and induces hallmarks of the epithelial-to-mesenchymal transition in ovarian cancer cells. In summary, we have confirmed the tumor-suppressive function of TUSC3 and identified the possible mechanism driving TUSC3-deficient ovarian cancer cells toward a malignant phenotype.

Citing Articles

Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids.

Papaccio F, Cabeza-Segura M, Garcia-Mico B, Gimeno-Valiente F, Zuniga-Trejos S, Gambardella V J Exp Clin Cancer Res. 2025; 44(1):77.

PMID: 40022181 PMC: 11869439. DOI: 10.1186/s13046-025-03308-8.


Glycan diversity in ovarian cancer: Unraveling the immune interplay and therapeutic prospects.

Wolters-Eisfeld G, Oliveira-Ferrer L Semin Immunopathol. 2024; 46(6):16.

PMID: 39432076 PMC: 11493797. DOI: 10.1007/s00281-024-01025-6.


Metabolism of primary high-grade serous ovarian carcinoma (HGSOC) cells under limited glutamine or glucose availability.

Simcikova D, Gardas D, Pelikan T, Moran L, Hruda M, Hlozkova K Cancer Metab. 2024; 12(1):27.

PMID: 39285269 PMC: 11403878. DOI: 10.1186/s40170-024-00355-1.


Intact cell mass spectrometry coupled with machine learning reveals minute changes induced by single gene silencing.

Pecinka L, Moran L, Kovacovicova P, Meloni F, Havel J, Pivetta T Heliyon. 2024; 10(9):e29936.

PMID: 38707401 PMC: 11066331. DOI: 10.1016/j.heliyon.2024.e29936.


Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status.

Wu Q, Berglund A, Macaulay R, Etame A Int J Mol Sci. 2023; 24(20).

PMID: 37894860 PMC: 10606804. DOI: 10.3390/ijms242015179.